Dr Katy Clarke

Dr Katy Clarke is a dedicated Consultant Clinical Oncologist who specialises in the management and care of patients diagnosed with thoracic and urological cancers. Working alongside a wider multidisciplinary team of healthcare professionals, Dr Clarke provides structured, patient-focused care aimed at offering the most effective and supportive treatment pathways. Her practice prioritises individualised patient care, ensuring that every therapeutic plan is suited to the clinical needs and personal circumstances of the patient.

Her primary clinical interests include the treatment of lung malignancies and urological conditions. Dr Clarke possesses expertise in advanced radiotherapy techniques, particularly stereotactic body radiotherapy for lung cancer, as well as positron emission tomography (PET) imaging to enhance precision in radiotherapy planning. In addition to radiation therapies, her clinical work encompasses systemic options such as chemotherapy and targeted treatments, applying precision oncology principles to achieve optimal treatment responses.

Alongside her routine clinical commitments, Dr Clarke is actively involved in clinical research and trial initiatives. She serves as a principal investigator on global studies evaluating novel therapies for advanced non-small cell lung cancer, striving to bring innovative treatments to her patients. Dr Clarke completed her primary medical degree, earning a Bachelor of Medicine, Bachelor of Surgery (MBChB), and subsequently obtained Membership of the Royal College of Physicians (MRCP) as well as Fellowship of the Royal College of Radiologists (FRCR). Through her professional college affiliations and research involvement, she remains at the forefront of modern oncological advancements.